DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Azathioprine

Azathioprine

  • Practice Guideline: Disease-Modifying Therapies for Adults with Multiple Sclerosis

    Practice Guideline: Disease-Modifying Therapies for Adults with Multiple Sclerosis

  • Leflunomide Affect Fertility Or Pregnancy?

    Leflunomide Affect Fertility Or Pregnancy?

  • Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Evectiveness and Cost?

    Systematic Review of Immunomodulatory Drugs for the Treatment of People with Multiple Sclerosis: Is There Good Quality Evidence on Evectiveness and Cost?

  • Imuran Data Sheet

    Imuran Data Sheet

  • Azathioprine As a Steroid Sparing Agent in Leprosy Type 2 Reactions: Report of Nine Cases

    Azathioprine As a Steroid Sparing Agent in Leprosy Type 2 Reactions: Report of Nine Cases

  • Immunomodulators

    Immunomodulators

  • Azathioprine (PDF, 34KB)

    Azathioprine (PDF, 34KB)

  • Azathioprine (In Conjunction with Prednisolone) ESCA: for the Treatment of Interstitial Lung Disease AREAS of RESPONSIBILITY for the SHARING of CARE

    Azathioprine (In Conjunction with Prednisolone) ESCA: for the Treatment of Interstitial Lung Disease AREAS of RESPONSIBILITY for the SHARING of CARE

  • The Influence of Immunosuppressants on Non-Melanoma Skin Cancer

    The Influence of Immunosuppressants on Non-Melanoma Skin Cancer

  • IMURAN ® (Azathioprine)

    IMURAN ® (Azathioprine)

  • I M M U N O L O G Y Core Notes

    I M M U N O L O G Y Core Notes

  • Supplementary Table S1. List of Diseases and Conditions Candidate to Be Tested As Predictors of One-Year Mortality

    Supplementary Table S1. List of Diseases and Conditions Candidate to Be Tested As Predictors of One-Year Mortality

  • Ethical Use of Off-Label Disease-Modifying Therapies for Multiple Sclerosis

    Ethical Use of Off-Label Disease-Modifying Therapies for Multiple Sclerosis

  • Use of Azathioprine for Nonthymoma Myasthenia and Risk of Cancer: A

    Use of Azathioprine for Nonthymoma Myasthenia and Risk of Cancer: A

  • 1. NAME of the MEDICINAL PRODUCT Azathioprin Orifarm 50 Mg Film-Coated Tablet

    1. NAME of the MEDICINAL PRODUCT Azathioprin Orifarm 50 Mg Film-Coated Tablet

  • MYFORTIC Safely and Effectively

    MYFORTIC Safely and Effectively

  • PROGRAF (Tacrolimus)

    PROGRAF (Tacrolimus)

  • Recurrent Pericarditis: Is Immunotherapy the Answer? Shir Azrielant MD1,3, Yehuda Shoenfeld MD, FRCP, MACR1,3,4 and Yehuda Adler MD, MHA2,3

    Recurrent Pericarditis: Is Immunotherapy the Answer? Shir Azrielant MD1,3, Yehuda Shoenfeld MD, FRCP, MACR1,3,4 and Yehuda Adler MD, MHA2,3

Top View
  • Sarcoidosis Treatment Guidelines
  • American Experience with Low-Dose Thalidomide Therapy for Severe Cutaneous Lupus Erythematosus
  • Mycophenolic Acid (As Mycophenolate Sodium) Teva Pharma B.V
  • Azathioprine (Imuran)/ 6-Mercaptopurine
  • Safety of Infliximab Used in Combination with Leflunomide Or Azathioprine in Daily Clinical Practice
  • Cladribine Tablets Approved As the First Short-Course Oral Treatment for RRMS in Switzerland 25.03.2019
  • Medication Guidelines for Solid Organ Transplants
  • Azathioprine (Imuran™) Information for Patients Why Am I Taking Azathioprine? Your Doctor Has Prescribed Azathioprine for the Treatment of Your Eye Condition
  • Use of Azathioprine in Adults: Safety
  • Mavenclad, INN-Cladribine
  • Proteinuria and Mammalian Target of Rapamycin Inhibitors in Renal Transplantation
  • M-TOR Inhibitors in Kidney Transplantation: a Comprehensive
  • Azathioprine) 50-Mg Scored Tablets Rx Only
  • Immunology; an Illustrated Outline; Sixth Edition
  • Drug Overviews
  • Azathioprine Factsheet Download
  • Choice of Immunosuppressants and the Risk of Warts in Renal Transplant Recipients
  • Graft-Versus-Host Disease Thalidomide After Allogeneic Haematopoietic Stem Cell Transplantation: Activity in Chronic but Not in Acute Graft-Versus-Host Disease


© 2024 Docslib.org    Feedback